Investigations and stories about the pharmaceutical market, access to medicines and public policies on health.
COVID-19 has paralysed mental health care, already weak in several European countries. During the first wave, 75% of psychiatry services were via telemedicine, but it doesn’t work for everybody.
For weeks, Spain and Italy were epicentres of the COVID-19 pandemic. Their health defences had an important gap.
The real cost that public administrations pay for CAR-T therapies is negotiated in secret, although the Ministry of Health does publish the maximum price it is willing to pay.
Together with sums of money they received from other laboratories, they were dished out a total of over 1.6 million. Most of them work in public hospitals.